1. At a Glance – Blink and You’ll Miss the Fluorine
Market cap ₹4,034 Cr. Stock at ₹4,044. Three-month return +3.9%, six-month return -8.2%. ROCE 41.8% and ROE 32% scream “capital efficiency”, while P/E 53.9x whispers “valuation ka practical exam chal raha hai.” Latest Q3 FY26 results show Revenue ₹173 Cr, PAT ₹15.6 Cr, with profit down 55% QoQ (yes, that hurt). Debt is pocket-change (₹31.5 Cr, D/E 0.09). Dividend yield 0.22%—don’t quit your job for that.
But here’s the masala: brownfield HF expansion done, solar-grade DHF commissioned, multi-year Japanese contracts signed, and forward integration plans cooking. Question is simple—is the chemistry still reacting, or has valuation evaporated the solvent?
2. Introduction – Fluorine, Fame, and a Few Fumes
Founded in 1972, Tanfac sits quietly in SIPCOT, Cuddalore, making chemicals that are dangerous enough to scare amateurs and profitable enough to excite veterans. Hydrofluoric Acid (HF) isn’t a college lab experiment; it’s hardcore industrial chemistry.
The stock has delivered 83% CAGR over 5 years, which explains the premium multiple. But Q3 FY26 slapped investors with a reality check—margins cooled, profits dipped, and the market asked: “Boss, growth story pause pe hai kya?”
Meanwhile, promoters include Tamil Nadu Industrial Development Corporation and Anupam Rasayan India Limited—a PSU-private combo that’s rare, stable, and occasionally bureaucratic. With fresh capex, QIP plans, and long-term contracts starting H2 FY26 onwards, this story is less about one quarter and more about execution vs expectations.
So… do you trust chemistry, or do you fear valuations? 🤔
3. Business Model – WTF Do They Even Do?
